deutsch    english

Registering

User:
Password:

Not registered yet?
Are you a doctor or a dealer in medical products and would like to receive more detailed information about our products?

Register: here

Support

For further information
and telephone support, you can contact us at:

+49 (0) 71 21 - 36 4 03 - 2 99
info(at)okuvision.de

A+ A++   Print

Okuvision can preserve eyesight

Okuvision is one of the first forms of outpatient treatment for retinitis pigmentosa, whose effectiveness has been proven by clinical studies*. About 20,000 people suffering from retinitis pigmentosa in Germany could profit from this.
It has been proven that the Okuvision therapy can delay the progress of the illness and thus preserve eyesight for a longer period. Its special feature: Okuvision transmits weak electrical impulses to the retina. This electronic stimulus to the retina helps to preserve eyesight for a longer period. Nevertheless, this Okuvision therapy for retinitis pigmentosa is hardly perceptible and as a rule causes no pain.

* Schatz, et al, IOVS June 2011

Please note: Our Product is not for sale in the US.

Products:

The OkuStim system gives retinitis pigmentosa patients the chance to positively influence the course of disease. It is recommended to administer the therapy under medical supervision. The OkuStim system consists of three essential components: the neurostimulator, OkuStim, the spectacle frame, OkuSpex and the electrode, OkuEl. Using the OkuStim system is easy and is adapted to the requirements of the individuals affected. OkuStim is equipped with an audio output so that even patients in a very advanced stage of the illness can operate it without difficulties.
More information on the components

Retinitis pigmentosa therapy: The OkuStim system with the neurostimulator, OkuStim, the spectacle frame, OkuSpex and the electrode, OkuEl. (click to enlarge)
Retinitis pigmentosa therapy: The OkuStim system with the neurostimulator, OkuStim, the spectacle frame, OkuSpex and the electrode, OkuEl. (click to enlarge)

News:

2014/07/08

New patient brochure is ready for download

The patient brochure has been reworked and redesigned concerning clarity.

more >
 
2014/06/23

Okuvision GmbH at RETINA INTERNATIONAL 2014

Okuvision GmbH is present on site in this year’s World Congress of Ophthalmology RETINA...

more >
 
2013/09/16

EURETINA, Hamburg 2013

Okuvision together with Retina Implant AG at the 13th EURETINA Congress in Hamburg (26-29...

more >